NO BP knows more about ADXS then Amgen who chose to partner with ADXS for NEO including what all ADXS shareholders want to see, UPFRONT money. Very significant that Amgen took a pass on AXAL. Yes to NEO, thumbs down on AXAL. If Amgen believed AXAL was the real deal, they would have partnered with ADXS for AXAL. However, Amgen, like all other BPs apparently think AXAL may a dud.